We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBWI icon
1001
Bath & Body Works
BBWI
$3.95B
$410K ﹤0.01%
12,832
-629
-5% -$20.9K
LYG icon
1002
Lloyds Banking Group
LYG
$85.6B
$410K ﹤0.01%
131,259
-45,157
-26% -$135K
GRMN
1003
Garmin
GRMN
$57.4B
$409K ﹤0.01%
2,326
+712
+44% +$123K
HLMN icon
1004
Hillman Solutions
HLMN
$1.56B
$409K ﹤0.01%
38,684
-25
-0.1% -$241
AVNT icon
1005
Avient
AVNT
$3.3B
$407K ﹤0.01%
8,084
+2,335
+41% +$107K
ALC icon
1006
Alcon
ALC
$33.9B
$406K ﹤0.01%
4,058
+229
+6% +$21.5K
GPI icon
1007
Group 1 Automotive
GPI
$4.42B
$406K ﹤0.01%
1,059
+264
+33% +$90.7K
BRKR icon
1008
Bruker
BRKR
$9.42B
$399K ﹤0.01%
5,772
+1,680
+41% +$109K
BOH icon
1009
Bank of Hawaii
BOH
$3.14B
$396K ﹤0.01%
6,315
+182
+3% +$11.7K
SON icon
1010
Sonoco
SON
$5.8B
$394K ﹤0.01%
7,220
+1,545
+27% +$80.8K
RY icon
1011
Royal Bank of Canada
RY
$288B
$394K ﹤0.01%
3,157
+165
+6% +$18.9K
PVH icon
1012
PVH
PVH
$4B
$392K ﹤0.01%
3,889
+29
+0.8% +$2.88K
TPL icon
1013
Texas Pacific Land
TPL
$26.9B
$390K ﹤0.01%
1,323
+39
+3% +$10.7K
KRC icon
1014
Kilroy Realty
KRC
$4.63B
$390K ﹤0.01%
10,080
-349
-3% -$12.3K
RXO icon
1015
RXO
RXO
$3.65B
$390K ﹤0.01%
13,923
+650
+5% +$18.4K
NTNX icon
1016
Nutanix
NTNX
$16.1B
$386K ﹤0.01%
6,519
-623
-9% -$34.2K
ORA icon
1017
Ormat Technologies
ORA
$5.8B
$384K ﹤0.01%
4,985
-310
-6% -$23K
ATKR icon
1018
Atkore
ATKR
$2.49B
$383K ﹤0.01%
4,523
+256
+6% +$27.8K
AMG icon
1019
Affiliated Managers Group
AMG
$9.66B
$382K ﹤0.01%
2,149
+637
+42% +$108K
DBEF icon
1020
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.14B
$378K ﹤0.01%
+9,000
New +$371K
XLB icon
1021
State Street Materials Select Sector SPDR ETF
XLB
$8.71B
$378K ﹤0.01%
7,836
-8,418
-52% -$384K
FUL icon
1022
H.B. Fuller
FUL
$3B
$377K ﹤0.01%
4,754
+287
+6% +$23.3K
B
1023
Barrick Mining
B
$60.8B
$374K ﹤0.01%
18,793
+2,638
+16% +$50.3K
WBD icon
1024
Warner Bros
WBD
$64.3B
$373K ﹤0.01%
45,256
-19,188
-30% -$150K
PRN icon
1025
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$387M
$373K ﹤0.01%
2,436

Similar funds

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.